Results 41 to 50 of about 20,461 (225)

Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions

International Journal of General Medicine, 2021
Manal M Alem Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaCorrespondence: Manal M AlemDepartment of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal ...
Alem MM
doaj  

Comparison of procedural outcomes in patients undergoing catheter vs surgical ablation for atrial fibrillation and heart failure with reduced ejection fraction

Journal of Arrhythmia, 2021
Background There is a lack of research comparing procedural outcomes of surgical ablation (SA) and catheter ablation (CA) among patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AF).
Rajkumar Doshi, Ashish Kumar, Mariam Shariff, Devina Adalja, Krunalkumar Patel, Kirtenkumar Patel, Rupak Desai, Nageshwara Gullapalli, Saraschandra Vallabhajosyula   +8 more
doaj   +1 more source

Risk factors for new-onset heart failure with reduced or preserved ejection fraction in patients with ischemic heart disease: A cohort study

Journal of Clinical Sciences, 2021
Background: Risk factors for heart failure (HF) with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF) in Ethiopian and Sub-Saharan African patients with ischemic heart disease (IHD) is not well-known.
Senbeta Guteta Abdissa
doaj   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Comparative Effects of 12 Weeks of Center-Based versus Home-Based Exercise Training on hs-CRP and IL-6 Levels in Patients with Heart Failure Reduced Ejection Fraction

Український журнал серцево-судинної хірургії
Introduction. Heart failure (HF) is a global health concern characterized by significant morbidity and mortality, often associated with chronic systemic inflammation.
Daniel Susilo Lawrence, Akhtar Fajar Muzakkir, Yulius Patimang, Muzakkir Amir, Zaenab Djafar, Melda Warliani, Andi Alfian Zainuddin   +6 more
doaj   +1 more source

The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence

Therapeutics and Clinical Risk Management, 2021
Manasvi Gupta,1 Shiavax Rao,2 Gaurav Manek,1 Gregg C Fonarow,3 Raktim K Ghosh4 1Department of Internal Medicine, University of Connecticut, Hartford, CT, USA; 2Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA; 3Department of ...
Gupta M, Rao S, Manek G, Fonarow GC, Ghosh RK   +4 more
doaj  

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Correlation of the decrease in exercise tolerance with the ventilation and gas exchange disturbances in patients with various phenotypes of chronic heart failure

Клинический разбор в общей медицине
Aim. To assess parameters of ventilation and gas exchange and determine the factors associated with the peak oxygen consumption levels in patients with various phenotypes of chronic heart failure (CHF). Methods. The study was focused on further analysis
Yulia L. Begrambekova, Nino A. Karanadze, Artem N. Zadoia, Elena M. Seredenina, Alina G. Plisyuk   +4 more
doaj   +1 more source

Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model

Health Technology Assessment, 2017
Background: Heart failure (HF) affects around 500,000 people in the UK. HF medications are frequently underprescribed and B-type natriuretic peptide (BNP)-guided therapy may help to optimise treatment.
Maria Pufulete, Rachel Maishman, Lucy Dabner, Syed Mohiuddin, William Hollingworth, Chris A Rogers, Julian Higgins, Mark Dayer, John Macleod, Sarah Purdy, Theresa McDonagh, Angus Nightingale, Rachael Williams, Barnaby C Reeves   +13 more
doaj   +1 more source

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding

Cells, 2020
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—
Steven J. Simmonds, Ilona Cuijpers, Stephane Heymans, Elizabeth A. V. Jones   +3 more
doaj   +1 more source